Metacrine’s IPO

Wilson Sonsini Goodrich & Rosati advised Metacrine, Inc. on the deal. Metacrine, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients...

This content is for Standard 1 Year members only.
Login Join Now